By Dr Ligia Kiss, Lecturer in Social Epidemiology and Dr Ben Cislaghi, Lecturer in social norms at the London School of Hygiene & Tropical Medicine.
In a favela in Rio de Janeiro recently, a 16-year-old girl woke up in a house she did not know, surrounded by more than thirty men, some armed, who claimed to have had sex with her. She did not remember what had happened after going to her boyfriend’s house the night before. After waking up from a drug-induced state of unconsciousness, she went home wearing men’s clothes and didn’t mention anything to her family. Read more
Laura Rodrigues, Professor of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine, is studying mothers and babies affected by Zika virus in Brazil. (Interview by Robert Colville.) Read more
By Catherine Pitt, Lecturer in Health Economics at the London School of Hygiene & Tropical Medicine.
Babies born in poor countries can be 50 times more likely to die in their first month of life than babies born in rich countries. In the safest country in the world for newborns, Japan, 1 of every 1000 newborn babies die in their first four weeks of life. In the United Kingdom, 3 of every 1000 newborn babies die. But in Sierra Leone, the most dangerous country for newborns, 50 of every 1000 newborn babies die in their first month – one death for every 20 babies born. Read more
By Carolyn Nielsen, PhD student: essay shortlisted for Max Perutz Science Writing Award.
It sounds like a bad science fiction plot, but sometimes it would be easier if everyone was identical.
I’m interested in how vaccines activate our immune systems and how this then works in the real world to protect us from dangerous infections. The problem is that not everyone’s immune cells respond in exactly the same way, meaning vaccines often work better in some people than in others. This can be at a local level, such as between your colleagues at work, or on a grander scale with differences between whole geographical regions. For example we know that BCG, the vaccine for tuberculosis, is less effective in sub-Saharan Africa than here in the UK.
By Dr Cathy Zimmerman, Reader in Gender Violence and Health at the School.
The recent image of the body of a dead three-old boy on a Turkish beach seized the world’s attention and provoked the worst nightmare of parents everywhere. This photo, which warrants the international outrage it has received, sadly only hints at the full panorama of childhood horrors that occur around the world each day.
In recent months while one migration crisis has followed another, alongside and worlds away from the children fleeing bullets and bombs, are unseen millions of girls and boys who are also suffering aborted childhoods and forced to navigate a universe of adult perils in the form of forced and trafficked child labour. But, what happens to the children who survive these abuses? Read more
Inspirational film released to mark the day Queen Elizabeth II becomes the longest serving monarch. Read more
By Dr Mark Jit, Senior Lecturer in Vaccine Epidemiology.
Year 8 schoolgirls in the UK (12-13 years old) receive two doses each of a vaccine against human papillomavirus (HPV), a virus that causes cervical cancer as well as genital warts and a number of other unpleasant cancers. Until 2013, they received three doses of the vaccine each. Read more
By Dr Kirstin Mitchell, Lecturer in Sexual and Reproductive Health at the School.
I was disheartened to learn last week that the US Federal Drug Administration approved flibanserin for treatment of low female sexual desire. The decision was claimed as a victory for women. But as a researcher working in sexual dysfunction and interested in the medicalisation of sex, the victory tasted a little bitter. Read more
By Dr Ankur Gupta-Wright, Clinical Research Fellow at the School.
Recent positive results from the Guinea Ebola vaccine trial, which suggested a vaccine could provide high protection against the virus, were welcome news. However, it’s also essential that we continue to carry out research to ensure Ebola patients are receiving appropriate care and effective treatment. Read more
The London School of Hygiene & Tropical Medicine has been ranked top university in Europe for research impact in all fields (ahead of Oxford and Cambridge) in the 2015 CWTS Leiden Ranking. The School is also ranked 6th overall in the world for impact based on the top 1% of published papers in all fields (after MIT, Harvard, Caltech, Stanford and Berkeley), 3rd in the world for biomedical and health sciences (after only MIT and Caltech) and 5th in the world overall for collaborative research. Read more